Acceleron blood disease drug hits goal in pivotal clinical trial
(By Adam Feurerstein for STAT) Acceleron Pharma said Thursday that its experimental drug luspatercept significantly reduced the need for blood
Read More
Kentucky’s hep A outbreak ‘worst on record’
(By Harrison Cook for Becker’s Hospital Review) Kentucky public health officials confirmed 969 cases of Hepatitis A in the state
Read MoreHealth care costs in retirement
Tail risk is a catchphrase that Wall Street likes to use to label a dramatic outlier event that upends the
Read More340B hospitals, contract pharmacies need more
The Government Accountability Office (GAO) said that HHS’ Health Resources and Services Administration (HRSA) should take new steps to ensure
Read More5 latest FDA approvals
(By Mackenzie Bean for Becker’s Hospital Review) Here are the five latest drugs or medical devices approved by the FDA
Read MoreAre we spending too much on the dying? New research challenges this widely held view
(By Orly Nadell Farber for STAT) Maybe you have heard the refrain before: The U.S. spends too much money on
Read MoreTop Policy Expert’s Ties To Giant Drugmaker Often Go Unstated
(By Sarah Jane Tribble for Kaiser Health News) When Dr. Mark McClellan sat for an in-depth 30-minute question-and-answer session at an April
Read MoreCMS boosting Medicaid audits, oversight to ‘strengthen safety net’
(By Kelly Gooch for Becker’s Hospital Review) CMS is increasing Medicaid audits and oversight of the program, according to a
Read MoreMedicare is extending its offer of relief from penalties for certain Medicare beneficiaries
Medicare is extending its offer of relief from penalties for certain Medicare beneficiaries who enrolled in Medicare Part A and
Read MoreFeds charge 601 suspects in biggest healthcare fraud raid to date
(By Kelly Gooch for Becker’s Hospital Review) Federal officials charged 601 defendants in alleged schemes involving about $2 billion in
Read More